283 related articles for article (PubMed ID: 31455413)
1. Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients.
La Rosa F; Agostini S; Bianchi A; Nemni R; Piancone F; Marventano I; Mancuso R; Saresella M; Clerici M
J Transl Med; 2019 Aug; 17(1):286. PubMed ID: 31455413
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.
Costa AS; Agostini S; Guerini FR; Mancuso R; Zanzottera M; Ripamonti E; Racca V; Nemni R; Clerici M
J Alzheimers Dis; 2017; 60(3):1055-1063. PubMed ID: 28984602
[TBL] [Abstract][Full Text] [Related]
3. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3.
Melchjorsen J; Sirén J; Julkunen I; Paludan SR; Matikainen S
J Gen Virol; 2006 May; 87(Pt 5):1099-1108. PubMed ID: 16603509
[TBL] [Abstract][Full Text] [Related]
4. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
5. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
[TBL] [Abstract][Full Text] [Related]
6. Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity.
Jiang Z; Su C; Zheng C
J Virol; 2016 Dec; 90(24):11056-11061. PubMed ID: 27681138
[TBL] [Abstract][Full Text] [Related]
7. Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.
Loiacono CM; Myers R; Mitchell WJ
J Virol; 2002 Mar; 76(5):2449-59. PubMed ID: 11836423
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.
Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y
J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181
[TBL] [Abstract][Full Text] [Related]
9. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.
Philip DT; Goins NM; Catanzaro NJ; Misumi I; Whitmire JK; Atkins HM; Lazear HM
mBio; 2024 Apr; 15(4):e0262323. PubMed ID: 38426749
[TBL] [Abstract][Full Text] [Related]
10. pUL36 Deubiquitinase Activity Augments Both the Initiation and the Progression of Lytic Herpes Simplex Virus Infection in IFN-Primed Cells.
Mohnke J; Stark I; Fischer M; Fischer PM; Schlosser A; Grothey A; O'Hare P; Sodeik B; Erhard F; Dölken L; Hennig T
J Virol; 2022 Nov; 96(22):e0096322. PubMed ID: 36314822
[TBL] [Abstract][Full Text] [Related]
11. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.
Pan D; Pesola JM; Li G; McCarron S; Coen DM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847363
[TBL] [Abstract][Full Text] [Related]
12. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
Parker ZM; Pasieka TJ; Parker GA; Leib DA
J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
[TBL] [Abstract][Full Text] [Related]
13. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.
Kobayashi N; Nagata T; Shinagawa S; Oka N; Shimada K; Shimizu A; Tatebayashi Y; Yamada H; Nakayama K; Kondo K
Biochem Biophys Res Commun; 2013 Jan; 430(3):907-11. PubMed ID: 23261465
[TBL] [Abstract][Full Text] [Related]
14. A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.
Griffiths SJ; Koegl M; Boutell C; Zenner HL; Crump CM; Pica F; Gonzalez O; Friedel CC; Barry G; Martin K; Craigon MH; Chen R; Kaza LN; Fossum E; Fazakerley JK; Efstathiou S; Volpi A; Zimmer R; Ghazal P; Haas J
PLoS Pathog; 2013; 9(8):e1003514. PubMed ID: 23950709
[TBL] [Abstract][Full Text] [Related]
15. IFN-λ Regulates Neutrophil Biology to Suppress Inflammation in Herpes Simplex Virus-1-Induced Corneal Immunopathology.
Antony F; Pundkar C; Sandey M; Jaiswal AK; Mishra A; Kumar A; Channappanavar R; Suryawanshi A
J Immunol; 2021 Apr; 206(8):1866-1877. PubMed ID: 33811102
[TBL] [Abstract][Full Text] [Related]
16. A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo.
Cui B; Carr DJ
J Neuroimmunol; 2000 Aug; 108(1-2):92-102. PubMed ID: 10900342
[TBL] [Abstract][Full Text] [Related]
17. Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.
Jiang X; Brown D; Osorio N; Hsiang C; BenMohamed L; Wechsler SL
J Neurovirol; 2016 Feb; 22(1):38-49. PubMed ID: 26069184
[TBL] [Abstract][Full Text] [Related]
18. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
Loiacono CM; Taus NS; Mitchell WJ
J Neurovirol; 2003 Jun; 9(3):336-45. PubMed ID: 12775417
[TBL] [Abstract][Full Text] [Related]
19. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.
Bourgade K; Le Page A; Bocti C; Witkowski JM; Dupuis G; Frost EH; Fülöp T
J Alzheimers Dis; 2016; 50(4):1227-41. PubMed ID: 26836158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
